<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma]]></title><description><![CDATA[Farmaceutisk industri]]></description><link>https://dev.proinvestor.com/forum/category/20</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 23:48:04 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/category/20.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 05 May 2026 04:07:10 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Pharma — Maj 2026]]></title><description><![CDATA[ALK-Abelló får løftet kursmål til 300 kr. fra 280 kr. hos ABG https://proinvestor.com/investornyt/1440297/alk-abello-far-loftet-kursmal-til-300-kr-fra-280-kr-hos-abg
]]></description><link>https://dev.proinvestor.com/forum/topic/400910/pharma-maj-2026</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400910/pharma-maj-2026</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 05 May 2026 04:07:10 GMT</pubDate></item><item><title><![CDATA[Pharma — April 2026]]></title><description><![CDATA[OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1427678/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
]]></description><link>https://dev.proinvestor.com/forum/topic/400909/pharma-april-2026</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400909/pharma-april-2026</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 01 Apr 2026 05:58:34 GMT</pubDate></item><item><title><![CDATA[Pharma — Marts 2026]]></title><description><![CDATA[Test
]]></description><link>https://dev.proinvestor.com/forum/topic/400908/pharma-marts-2026</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400908/pharma-marts-2026</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 23 Mar 2026 06:07:40 GMT</pubDate></item><item><title><![CDATA[Pharma — Februar 2026]]></title><description><![CDATA[ALK-Abelló får hævet sit kursmål til 255 kr. fra 185 kr. hos Jefferies https://proinvestor.com/investornyt/1409947/alk-abello-far-haevet-sit-kursmal-til-255-kr-fra-185-kr-hos-jefferies
]]></description><link>https://dev.proinvestor.com/forum/topic/400907/pharma-februar-2026</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400907/pharma-februar-2026</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 03 Feb 2026 05:11:47 GMT</pubDate></item><item><title><![CDATA[Pharma — Januar 2026]]></title><description><![CDATA[Europæiske life science-aktier tager teten efter afvist sparemanøvre fra Trump https://proinvestor.com/investornyt/1400080/europaeiske-life-science-aktier-tager-teten-efter-afvist-sparemanovre-fra-trump
]]></description><link>https://dev.proinvestor.com/forum/topic/400906/pharma-januar-2026</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400906/pharma-januar-2026</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 06 Jan 2026 10:50:26 GMT</pubDate></item><item><title><![CDATA[Pharma — December 2025]]></title><description><![CDATA[The Healthcare Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. https://proinvestor.com/investornyt/1390543/the-healthcare-sector-is-surging-heres-1-stock-every-investor-should-have-on-their-radar
]]></description><link>https://dev.proinvestor.com/forum/topic/400905/pharma-december-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400905/pharma-december-2025</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Sat, 06 Dec 2025 15:11:58 GMT</pubDate></item><item><title><![CDATA[Pharma — November 2025]]></title><description><![CDATA[Danske kvartalsregnskaber: Nu gælder det https://proinvestor.com/boards/129367
]]></description><link>https://dev.proinvestor.com/forum/topic/400904/pharma-november-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400904/pharma-november-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 03 Nov 2025 07:45:54 GMT</pubDate></item><item><title><![CDATA[Pharma — Oktober 2025]]></title><description><![CDATA[Flere dages kursstigninger - er trenden positiv? Genmab, Novo Nordisk, Zealand Pharma, Gubra . Kort video: https://proinvestor.com/boards/128686
]]></description><link>https://dev.proinvestor.com/forum/topic/400903/pharma-oktober-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400903/pharma-oktober-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 02 Oct 2025 15:13:01 GMT</pubDate></item><item><title><![CDATA[Pharma — September 2025]]></title><description><![CDATA[Pharma og biotek har længe været kursmæssigt underdrejet - selv store, sunde pharma-selskaber. Mange investorer har søgt over i f.eks. amerikanske tech-aktier. Men er den tendens ved at vende? Er bunden fundet for pharma og biotek? Skal det bare gå opad nu? Det spørgsmål giver Helge Larsen sit svar på i denne ugekommentar, hvor han også kommer ind på teknisk analyse og algoritmehandels rolle på aktiemarkedet. Kort video: https://proinvestor.com/boards/128230
]]></description><link>https://dev.proinvestor.com/forum/topic/400902/pharma-september-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400902/pharma-september-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 04 Sep 2025 10:43:59 GMT</pubDate></item><item><title><![CDATA[Pharma — August 2025]]></title><description><![CDATA[Lundbecks kursmål sænkes til 50 kr. fra 53 kr. af DNB Carnegie https://proinvestor.com/investornyt/1347926/lundbecks-kursmal-saenkes-til-50-kr-fra-53-kr-af-dnb-carnegie
]]></description><link>https://dev.proinvestor.com/forum/topic/400901/pharma-august-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400901/pharma-august-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 06 Aug 2025 13:46:46 GMT</pubDate></item><item><title><![CDATA[Pharma — Juli 2025]]></title><description><![CDATA[Lundbeck får indledt dækning hos fransk finanshus med neutral anbefaling https://proinvestor.com/investornyt/1334843/lundbeck-far-indledt-daekning-hos-fransk-finanshus-med-neutral-anbefaling
]]></description><link>https://dev.proinvestor.com/forum/topic/400900/pharma-juli-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400900/pharma-juli-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 01 Jul 2025 03:06:24 GMT</pubDate></item><item><title><![CDATA[Pharma — Juni 2025]]></title><description><![CDATA[Fedmemarkedet handler primært om glp1, senere er amylin blevet kendt, men det dansk-svenske biotekselskab Pila Pharma, grundlagt af Dorte X. Gram med rødder i Novo Nordisk, udvikler en oral behandling mod type 2-diabetes og fedme baseret på en såkaldt chili-receptor. Hør mere i denne video, hvor Helge Larsen har besøg af Dorte X. Gram https://proinvestor.com/boards/126647
]]></description><link>https://dev.proinvestor.com/forum/topic/400899/pharma-juni-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400899/pharma-juni-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 05 Jun 2025 15:50:49 GMT</pubDate></item><item><title><![CDATA[Pharma — Maj 2025]]></title><description><![CDATA[Danske Bank sænker Lundbeck-kursmål grundet told og valuta - men ser stærkt start på året https://proinvestor.com/investornyt/1312304/danske-bank-saenker-lundbeck-kursmal-grundet-told-og-valuta-men-ser-staerkt-start-pa-aret
]]></description><link>https://dev.proinvestor.com/forum/topic/400898/pharma-maj-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400898/pharma-maj-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 05 May 2025 06:06:46 GMT</pubDate></item><item><title><![CDATA[Pharma — April 2025]]></title><description><![CDATA[Toldplan: Tæt på worst case, men er der lyspunkter? https://proinvestor.com/boards/125530
]]></description><link>https://dev.proinvestor.com/forum/topic/400897/pharma-april-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400897/pharma-april-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 03 Apr 2025 02:34:30 GMT</pubDate></item><item><title><![CDATA[Pharma — Marts 2025]]></title><description><![CDATA[Gubra aktien pt. kraftigt oversolgt. Med den nye aftale er prisen helt skæv. Imho.
]]></description><link>https://dev.proinvestor.com/forum/topic/400896/pharma-marts-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400896/pharma-marts-2025</guid><dc:creator><![CDATA[Finansen]]></dc:creator><pubDate>Thu, 06 Mar 2025 08:25:32 GMT</pubDate></item><item><title><![CDATA[Det er open label så der kan også være set responser ?]]></title><description><![CDATA[Det er open label så der kan også være set responser ?
]]></description><link>https://dev.proinvestor.com/forum/topic/398566/det-er-open-label-s-der-kan-ogs-vre-set-responser</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/398566/det-er-open-label-s-der-kan-ogs-vre-set-responser</guid><dc:creator><![CDATA[c3po]]></dc:creator><pubDate>Thu, 20 Feb 2025 22:35:10 GMT</pubDate></item><item><title><![CDATA[Pharma — Februar 2025]]></title><description><![CDATA[Lundbeck OVERBLIK Q4: Omsætning skuffer let men nyeste lægemiddel fortsætter vækst https://proinvestor.com/investornyt/1274030/lundbeck-overblik-q4-omsaetning-skuffer-let-men-nyeste-laegemiddel-fortsaetter-vaekst
]]></description><link>https://dev.proinvestor.com/forum/topic/400895/pharma-februar-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400895/pharma-februar-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 05 Feb 2025 06:57:05 GMT</pubDate></item><item><title><![CDATA[Pharma — Januar 2025]]></title><description><![CDATA[Danske helårsregnskaber 2024: Fokus på guidance, moderat vækst og fremtidens USA https://proinvestor.com/boards/123960
]]></description><link>https://dev.proinvestor.com/forum/topic/400894/pharma-januar-2025</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400894/pharma-januar-2025</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 07 Jan 2025 05:47:21 GMT</pubDate></item><item><title><![CDATA[Pharma — December 2024]]></title><description><![CDATA[Lundbeck gennemfører opkøb af Longboard Pharmaceuticals https://proinvestor.com/investornyt/1249382/lundbeck-gennemforer-opkob-af-longboard-pharmaceuticals
]]></description><link>https://dev.proinvestor.com/forum/topic/400893/pharma-december-2024</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400893/pharma-december-2024</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 02 Dec 2024 14:33:34 GMT</pubDate></item><item><title><![CDATA[Pharma — November 2024]]></title><description><![CDATA[ALK-Abelló opnår rettigheder til næsespray mod allergisk shock https://proinvestor.com/investornyt/1240801/alk-abello-opnar-rettigheder-til-naesespray-mod-allergisk-shock
]]></description><link>https://dev.proinvestor.com/forum/topic/400892/pharma-november-2024</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400892/pharma-november-2024</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 11 Nov 2024 05:07:51 GMT</pubDate></item><item><title><![CDATA[Pharma — Oktober 2024]]></title><description><![CDATA[Danske Bank ser mulighed for mere udlodning fra Lundbeck https://proinvestor.com/investornyt/1223637/danske-bank-ser-mulighed-for-mere-udlodning-fra-lundbeck
]]></description><link>https://dev.proinvestor.com/forum/topic/400891/pharma-oktober-2024</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400891/pharma-oktober-2024</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 07 Oct 2024 11:31:36 GMT</pubDate></item><item><title><![CDATA[Pharma — September 2024]]></title><description><![CDATA[What's Behind The 2x Jump In AbbVie Stock? https://proinvestor.com/investornyt/1208910/whats-behind-the-2x-jump-in-abbvie-stock
]]></description><link>https://dev.proinvestor.com/forum/topic/400890/pharma-september-2024</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400890/pharma-september-2024</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 04 Sep 2024 02:09:48 GMT</pubDate></item><item><title><![CDATA[Pharma — August 2024]]></title><description><![CDATA[Madrigal's MASH drug Rezdiffra blows past estimates in Q2 https://firstwordpharma.com/story/5883184
]]></description><link>https://dev.proinvestor.com/forum/topic/400889/pharma-august-2024</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400889/pharma-august-2024</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 08 Aug 2024 03:12:26 GMT</pubDate></item><item><title><![CDATA[Pharma — Juli 2024]]></title><description><![CDATA[BioArctic's Partner Eisai Says Leqembi Approved In Hong Kong For Alzheimer's Disease Treatment https://proinvestor.com/investornyt/1183677/bioarctics-partner-eisai-says-leqembi-approved-in-hong-kong-for-alzheimers-disease-treatment
]]></description><link>https://dev.proinvestor.com/forum/topic/400888/pharma-juli-2024</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400888/pharma-juli-2024</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 11 Jul 2024 01:56:16 GMT</pubDate></item><item><title><![CDATA[Pharma — Juni 2024]]></title><description><![CDATA[Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030 https://proinvestor.com/investornyt/1167710/prediction-these-could-be-the-best-performing-pharmaceutical-stocks-through-2030
]]></description><link>https://dev.proinvestor.com/forum/topic/400887/pharma-juni-2024</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/topic/400887/pharma-juni-2024</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sun, 02 Jun 2024 13:07:38 GMT</pubDate></item></channel></rss>